CR20130618A - Síntesis quiral de n-{3,4-difluoro-2-[(2-fluoro-4-yodofenil)amino]-6-metoxinfenil}-1-[2,3-dihidroxi-propil]ciclopropanosulfonamidas - Google Patents

Síntesis quiral de n-{3,4-difluoro-2-[(2-fluoro-4-yodofenil)amino]-6-metoxinfenil}-1-[2,3-dihidroxi-propil]ciclopropanosulfonamidas

Info

Publication number
CR20130618A
CR20130618A CR20130618A CR20130618A CR20130618A CR 20130618 A CR20130618 A CR 20130618A CR 20130618 A CR20130618 A CR 20130618A CR 20130618 A CR20130618 A CR 20130618A CR 20130618 A CR20130618 A CR 20130618A
Authority
CR
Costa Rica
Prior art keywords
iodophenyl
difluoro
fluoro
amino
metoxinfenil
Prior art date
Application number
CR20130618A
Other languages
English (en)
Inventor
Peter Fey
Agathe Christine Mayer
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46172787&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20130618(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of CR20130618A publication Critical patent/CR20130618A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/71—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/78—Halides of sulfonic acids
    • C07C309/79—Halides of sulfonic acids having halosulfonyl groups bound to acyclic carbon atoms
    • C07C309/82—Halides of sulfonic acids having halosulfonyl groups bound to acyclic carbon atoms of a carbon skeleton substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/28—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/34—Compounds containing oxirane rings with hydrocarbon radicals, substituted by sulphur, selenium or tellurium atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a un novedoso método enantioselectivo para preparar enantiómeros (S)- y (R)- de N-{3,4-difluoro-2-[(2-fluoro-4-yodofenil)amino]-6-5-metoxifenil}-1-[2,3-dihidroxi-propil]ciclopropanosulfonamida, a compuestos intermediarios novedosos, y al uso de dichos compuestos intermediarios novedosos para la preparación de dichos enantiómeros (S)- y (R)- de N-{3,4-difluoro-2-[(2-fluoro-4-yodofenil)amino]-6-metoxifenil}-1-[2,3-dihidroxi-propil]ciclopropanosulfonamida:
CR20130618A 2011-05-27 2013-11-22 Síntesis quiral de n-{3,4-difluoro-2-[(2-fluoro-4-yodofenil)amino]-6-metoxinfenil}-1-[2,3-dihidroxi-propil]ciclopropanosulfonamidas CR20130618A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11167806 2011-05-27

Publications (1)

Publication Number Publication Date
CR20130618A true CR20130618A (es) 2014-01-09

Family

ID=46172787

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20130618A CR20130618A (es) 2011-05-27 2013-11-22 Síntesis quiral de n-{3,4-difluoro-2-[(2-fluoro-4-yodofenil)amino]-6-metoxinfenil}-1-[2,3-dihidroxi-propil]ciclopropanosulfonamidas

Country Status (30)

Country Link
US (1) US9328066B2 (es)
EP (1) EP2714652B8 (es)
JP (1) JP5965993B2 (es)
KR (1) KR101939682B1 (es)
CN (1) CN103596921B (es)
AP (1) AP2013007257A0 (es)
AR (1) AR086553A1 (es)
AU (1) AU2012264884B2 (es)
BR (1) BR112013030387A2 (es)
CA (1) CA2837162C (es)
CL (1) CL2013003387A1 (es)
CO (1) CO6862147A2 (es)
CR (1) CR20130618A (es)
CU (1) CU20130156A7 (es)
DO (1) DOP2013000278A (es)
EA (1) EA026550B1 (es)
EC (1) ECSP13013042A (es)
ES (1) ES2682247T3 (es)
GT (1) GT201300294A (es)
IL (1) IL228911A (es)
MA (1) MA35159B1 (es)
MX (1) MX362823B (es)
MY (1) MY186875A (es)
NZ (1) NZ616783A (es)
PE (1) PE20140580A1 (es)
SG (1) SG194544A1 (es)
TN (1) TN2013000492A1 (es)
TW (1) TWI551579B (es)
UA (1) UA113850C2 (es)
WO (1) WO2012163799A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013094546A1 (ja) * 2011-12-19 2013-06-27 住友化学株式会社 スルホン酸塩の製造方法
EP2848246A1 (en) 2013-09-13 2015-03-18 Bayer Pharma Aktiengesellschaft Pharmaceutical compositions containing refametinib

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101799B2 (en) * 2005-07-21 2012-01-24 Ardea Biosciences Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
DE102005042742A1 (de) 2005-09-02 2007-03-08 Schering Ag Substituierte Imidazo[1,2b]pyridazine als Kinase-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel
BRPI0615838A2 (pt) * 2005-09-14 2011-05-31 Janssen Pharmaceutica Nv 5-oxo-5,8-dihidro-pirido-pirimidinas como inibidores de ofc-fms cinase
US7842836B2 (en) 2006-04-11 2010-11-30 Ardea Biosciences N-aryl-N'alkyl sulfamides as MEK inhibitors
CA2660546A1 (en) 2006-08-21 2008-02-28 Genentech, Inc. Aza-benzofuranyl compounds and methods of use
EP1900739A1 (en) 2006-08-30 2008-03-19 Cellzome Ag Diazolodiazine derivatives as kinase inhibitors
EP2184984A4 (en) * 2007-07-30 2013-07-24 Ardea Biosciences Inc N- (ARYLAMINO) ARYLSULFONAMIDE DERIVATIVES COMPRISING POLYMORPHS AS MEK INHIBITORS AND COMPOSITIONS, METHODS OF USE AND PREPARATION METHODS THEREOF
CN102134218A (zh) 2009-06-15 2011-07-27 凯美隆(北京)药业技术有限公司 6-芳氨基吡啶酮磺酰胺和6-芳氨基吡嗪酮磺酰胺mek抑制剂
TWI524890B (zh) * 2009-07-24 2016-03-11 亞德生化公司 （ｒ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺及（ｓ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺之製備

Also Published As

Publication number Publication date
EA026550B1 (ru) 2017-04-28
US20140155637A1 (en) 2014-06-05
CN103596921A (zh) 2014-02-19
ECSP13013042A (es) 2014-01-31
MX362823B (es) 2019-02-18
TN2013000492A1 (en) 2015-03-30
MY186875A (en) 2021-08-26
IL228911A (en) 2017-10-31
AP2013007257A0 (en) 2013-11-30
EP2714652B8 (en) 2018-09-05
MX2013013667A (es) 2014-08-01
DOP2013000278A (es) 2013-12-31
UA113850C2 (xx) 2017-03-27
EP2714652B1 (en) 2018-07-18
JP5965993B2 (ja) 2016-08-10
US9328066B2 (en) 2016-05-03
EP2714652A1 (en) 2014-04-09
AR086553A1 (es) 2014-01-08
IL228911A0 (en) 2013-12-31
CA2837162C (en) 2019-04-02
TW201249791A (en) 2012-12-16
KR20140032433A (ko) 2014-03-14
CA2837162A1 (en) 2012-12-06
CO6862147A2 (es) 2014-02-10
BR112013030387A2 (pt) 2016-12-13
SG194544A1 (en) 2013-12-30
CL2013003387A1 (es) 2014-09-22
CU20130156A7 (es) 2014-02-28
AU2012264884A1 (en) 2013-11-07
GT201300294A (es) 2014-11-13
AU2012264884B2 (en) 2017-03-09
JP2014520087A (ja) 2014-08-21
PE20140580A1 (es) 2014-06-01
ES2682247T3 (es) 2018-09-19
MA35159B1 (fr) 2014-06-02
KR101939682B1 (ko) 2019-01-17
WO2012163799A1 (en) 2012-12-06
EA201301333A1 (ru) 2014-06-30
NZ616783A (en) 2016-01-29
TWI551579B (zh) 2016-10-01
CN103596921B (zh) 2016-08-03

Similar Documents

Publication Publication Date Title
AR094204A1 (es) Composiciones para el cuidado oral que contienen haluros de acido amino
ECSP12012221A (es) Anticuerpos anti-cd40
ECSP12011581A (es) Inhibidores de bace
BR112013023006A8 (pt) formulações de suspensões não aquosas de anticorpos de alta concentração e viscosidade reduzida
IN2015KN00262A (es)
MX356337B (es) Anticuerpos contra csf-1r humano y sus usos.
CR20140237A (es) Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
BR112012024312A2 (pt) anticorpos biespecíficos
PT2517700E (pt) Cocristais farmaceuticamente aceitáveis de n-[2-(7-metoxi- 1-naftil)etil]acetamida e métodos para a sua preparação
EA201390669A1 (ru) Способы и композиции для иммунотерапии заболеваний нервной системы
EA201591756A1 (ru) Метаболиты n-(4-{[6,7-бис-(метилокси)хинолин-4-ил]окси}фенил)-n'-(4-фторфенил)циклопропан-1,1-дикарбоксамида
EA201491153A1 (ru) КОМПОЗИЦИИ БУПРЕНОРФИНА И АНТАГОНИСТОВ μ-ОПИОИДНЫХ РЕЦЕПТОРОВ
WO2012175454A3 (fr) Méthode de dosage in vitro par technique immunologique
CR20130618A (es) Síntesis quiral de n-{3,4-difluoro-2-[(2-fluoro-4-yodofenil)amino]-6-metoxinfenil}-1-[2,3-dihidroxi-propil]ciclopropanosulfonamidas
GT201200328A (es) Intermedios de agomelatina y método de preparación de éstos
CY1115983T1 (el) Συνθεση toy aliskiren
MX2014012796A (es) Procedimiento para preparar n-(5-cloro-2-isopropilbencil) ciclopropanamina.
CO2019013718A2 (es) Anticuerpos anti-trkb
MX2013004881A (es) Proceso para la preparacion de n-(bencil)ciclopropanaminas sustituidas mediante hidrogenacion de iminas.
EA201291486A1 (ru) Получение тезетакселя и родственных соединений и соответствующего промежуточного продукта синтеза
CY1122772T1 (el) Πολυμορφα του υδροχλωρικου 4-μεθυλβενζοϊκου 4-[2-διμεθυλαμινο-1-(1-υδροξυκυκλοεξυλ)αιθυλ]φαινυλεστερα, μεθοδοι για την παρασκευη αυτων και χρηση αυτων
EA201400022A1 (ru) Способ получения кристаллических форм агомелатина и его новый полиморф
CR20130300A (es) Nuevo procedimiento de síntesis de la agomelatina
ES2395063R1 (es) Método para determinar la enfermedad de Alzheimer mediante la detección de glicoproteínas portadoras del glicoepítopo HNK-1
MX364906B (es) Proceso para la preparacion de n-(bencil) ciclopropanaminas sustituidas mediante hidrogenacion de iminas.